The induction of long-term potentiation at CA3-CA1 synapses is caused by an NMDA receptor-dependent accumulation of intracellular Ca 2+ , followed by Src family kinase activation and a positive feedback enhancement of NMDA receptors. Nevertheless, the amplitude of baseline transmission remains remarkably constant even though low frequency stimulation is also associated with an NMDA receptordependent influx of Ca 2+ into dendritic spines. We show here that an interaction between Cterminal Src kinase and NMDARs controls the Src-dependent regulation of NMDAR activity. C-terminal Src kinase associates with the NMDAR signalling complex in the adult brain, inhibiting the Src-dependent potentiation of NMDA receptors in CA1 neurons and attenuating the Src-dependent induction of long-term potentiation. In vitro C-terminal Src kinase associates directly with Src-phosphorylated NR2 subunits. An inhibitory antibody for Cterminal Src kinase disrupts this physical association, potentiates NMDA receptor-mediated excitatory postsynaptic currents and induces long-term potentiation at CA3-CA1 synapses. Thus, C-terminal Src kinase serves to maintain the constancy of baseline excitatory synaptic transmission by inhibiting Src kinasedependent synaptic plasticity in the hippocampus.
Pyramidal neurons of the CA1 hippocampus receive excitatory synaptic input from the axons of CA3 pyramidal neurons, which form the Schaffer Collateral pathway. The induction of synaptic plasticity at these CA3-CA1 synapses requires stimulation of NMDARs (N-methyl-Daspartate receptors) located at CA1 pyramidal cell dendritic spine synapses. It is widely accepted that spine depolarization relieves the Mg 2+ block of NMDARs, causing a concomitant increase in the influx of Ca 2+ . Both long-term potentiation (LTP) and long-term depression (LTD) are triggered by the subsequent accumulation of intracellular Ca 2+ in the spines. For example, induction of LTP increases Ca 2+ up to 10 μM whilst LTD is associated with lower but more sustained increases (1) . Appreciable NMDAR-dependent Ca 2+ influx occurs at spines even at resting membrane potential due to the relative incompleteness of the Mg 2+ block (2) . Therefore an NMDAR-dependent influx of Ca 2+ occurs even at low, baseline frequencies of stimulation that induce neither LTP nor LTD. This raises a fundamental question: Why does this baseline influx of Ca 2+ fail to induce synaptic plasticity?
Part of the answer to this question may lie in the observations that the induction of LTP at these synapses also requires activation of the Src family tyrosine kinases, Fyn and Src (3) . Src family kinases control the induction of LTP by potentiating the NMDAR-dependent influx of Ca 2+ (3) and activation of Src is "necessary and sufficient" to induce LTP at CA3-CA1 neurons (4) . Src facilitates NMDAR function likely by increasing tyrosine phosphorylation of the NR2A subunit while Fyn does so by phosphorylating the NR2B subunit (3) . The precise mechanism whereby Src and/or Fyn are activated during the induction of LTP is poorly understood. The influx of Ca 2+ likely enhances the tyrosine kinase Pyk2, which associates with and activates Src (3;5) . Therefore, activation of NMDARs and an influx of Ca 2+ are coupled to stimulation of Src, which is in turn responsible for increasing both NMDAR activity and the subsequent influx of Ca 2+ . During high frequency stimulation, relief of the Mg 2+ block of NMDARs is insufficient in itself for induction of long-term potentiation at CA3-CA1 synapses. This early Src-dependent positive feedback amplifies the NMDAR-dependent Ca 2+ signal (6) , allowing the activation of the appropriate downstream pathways (e.g. CamKII) responsible for enhancing the surface expression (7) and/or function of AMPARs (8) .
Surprisingly, during baseline stimulation intracellular applications of selective inhibitors of Pyk2 or Src are without effect on the amplitude of NMDAR-mediated excitatory postsynaptic currents (EPSCs) and thus fail to modify AMPARmediated EPSCs. However, they are highly effective in preventing the induction of LTP (4;9). These results are not consistent with a NMDARmediated Ca 2+ entry into postsynaptic spines during the baseline stimulation (2) . Indeed, such elemental Ca 2+ signals might be expected to be amplified by Src-mediated facilitation of NMDARs (positive feedback), which would subsequently and progressively facilitate AMPAR-mediated EPSPs. Intuitively, such a scheme would be undesirable for the maintenance of a stable neuronal network. A regulatory mechanism may therefore exist that holds Src in balance while leaving NMDARs unaffected until they are required for the induction of synaptic plasticity (e.g. LTP).
Csk family kinases (Csk, COOH-terminal Src kinase and Chk, Csk-homologous kinase) are cytosolic kinases which inhibit Src family kinases and as such are possible candidates for such a regulatory mechanism. Reports showing the downregulation of Csk in the adult brain and a parallel up-regulation of Chk suggest that Chk would be the most likely candidate (10;11). However, we present evidence that Csk is present at CA3-CA1 synapses and that it interacts directly with the NMDAR complex to regulate Src's ability to enhance NMDARs. Csk prevents an inappropriate activation of Src by the NMDAR-dependent influx of Ca 2+ that occurs during baseline stimulation frequencies and, in turn, inhibits the induction of LTP. Ours is the first demonstration that Csk plays a critical role in regulating the balance between baseline synaptic excitatory transmission and plasticity in the adult CNS.
Experimental Procedures
All animal experiments were conducted following the guidelines of the Canadian Council on Animal Care and the NIH, and were approved by the Animal Care Committee of the University of Toronto and the Animal Care and Use Committee of Florida State University. Acutely Isolated CA1 pyramidal neurons and electrophysiological recordings-Methods for acute neuron isolation from young adult rats have been previously described (12) . In brief, the hippocampi of postnatal (14-22 days) Wistar rats were dissected out and sliced into approximately 1 mm thick slices in ice-cold oxygenated extracellular solution and incubated for 45 mins followed by digestion with 2-3mg/ml crude papain extract for 30 mins at room temperature. The slices were then washed and incubated at room temperature for an additional 1-2 hrs prior to use (see supplementary information).
Acutely isolated CA1 pyramidal neurons present both advantages and disadvantages as a preparation for examining the function of NMDAR-mediated currents. The isolation procedure shears off much of the dendritic tree leaving only a few major primary and secondary dendritic branches. Applications of NMDA during whole cell recordings will therefore induce currents mediated by the activation of channels largely found within the extrasynaptic compartment. Nevertheless, some synaptic NMDARs are likely stimulated as many synapses are located on the large dendritic processes that come along with the cell soma. The predominant subtype of NMDAR in the extrasynaptic compartment of CA1 pyramidal neurons is NR1/NR2B. However, it is estimated that approximately 25% of the receptor compliment in this compartment is composed of NR1/NR2A receptors. This contrasts with the ~75% compliment of this receptor subtype at the synapse (13) . Furthermore, the peak open probability of NR1/2A receptors is about 2 to 5 times greater than for NR1/NRB receptors (14) . It is therefore anticipated that populations of both NR1/NR2A and NR1/NR2B receptors will contribute substantially to the peak whole cell currents recorded from isolated CA1 pyramidal neurons. Of course, we cannot rule out the possible presence of triheteromeric receptors.
Whole-cell clamped pyramidal neurons are lifted into the stream of a rapid perfusion system (see below). One of the significant advantages to this preparation is the ability to rapidly apply agonists and antagonists to the entirety of each cell and to attain near equilibrium conditions that are similar to those used to study recombinant NMDAR currents expressed in HEK293 cells (15;16) . It is far more difficult, if not impossible, to achieve such conditions with cultured hippo-campal neurons or with CA1 pyramidal neurons in situ in the slice preparation.
For whole-cell recordings, acutely isolated neurons were bathed with the extracellular solution containing (mM): NaCl (140), KCl (5.4), 1.3 CaCl 2 (1.3), HEPES (25) , glucose (33) , tetrodotoxin (0.001) and glycine (0.003), pH 7.4, osmolarity 310-320 mOsm. Recording pipettes were filled with intracellular solution containing (mM): CsCl or CsF (140), HEPES (10), MgCl 2 (2), BAPTA (1) and K 2 ATP (4), pH 7.2 and osmolarity 290-300 mOsm. DC resistances of recording electrodes were 4-6 MΩ. Input resistance was monitored by applying a voltage step of −10 mV and any recordings with more than a 20% change during the recording were rejected. Only recordings with a pipette-membrane seal > 2 GΩ were included.
For evoking NMDA receptor-mediated whole-cell responses, the standard and NMDA receptor agonist-containing extracellular solutions were rapidly applied through double-barrel glass to neurons using the SF-77B fast-step perfusion system (Warner Instruments).
Whole-cell NMDAR-mediated currents were recorded using an Axopatch 1D or Axopatch 200B amplifier (Molecular Devices) under voltage-clamp and a holding potential of -60mV except where otherwise indicated. For recordings from acutely isolated CA1 pyramidal neurons NMDA was applied at 50 μM in the continuing presence of 0.5 μM glycine. On-line data acquisition and off-line analysis were performed using pClamp8 software (Molecular Devices). Hippocampal slice preparation and electrophysiological recording-Techniques used for the hippocampal slice preparation and electrophysiological recording have been previously described (9;17) . In brief, hippocampal slices (400 μm) were prepared from 3-4 week-old Wistar rats. Slices recovered for 1h in oxygenated artificial cerebral spinal fluid (ACSF) containing (mM): NaCl (124), KCl (3), CaCl 2 (2.6), MgCl 2 (1.3), NaHCO 3 (26), NaH 2 PO 4 (1.25) and glucose (10), osmolarity 310-320mOsm, pH 7.4. Recording electrodes were filled with an intracellular solution containing (mM): K-gluconate (135.5), KCl (17.5), HEPES (10), EGTA (0.2), Mg-ATP (2), GTP (0.3) and QX 314 (5) with osmolarity 290-300mOsm and pH 7.2. DC resistances were 3-5mΩ. Series resistance (10-30 MOhm), monitored throughout the recording period, was estimated from the series resistance compensation of currents generated in response to 5 mV voltage steps. Cells were rejected if the resistance values changed by more than 20%. During recording, slices were continuously perfused at 3-5 ml/min with oxygenated and heated (30 o C -32 o C) ACSF. Synaptic responses were evoked with electrical stimulation at the border of the stratum radiatum-stratum lacunosum region. Stimuli were delivered at 0.05 or 0.1 Hz with the intensity adjusted to 25-30% of the maximal synaptic responses. Whole-cell EPSCs or EPSPs were recorded from the CA1 cell body layer using Multiclamp 700A amplifier and Clampex 9 software (Molecular Devices). During whole-cell recordings, field EPSPs (fEPSPs) were simultaneously recorded with electrodes filled with ACSF and placed within the stratum radiatum. Whole-cell EPSC recordings were conducted at -90 mV. After recording baseline synaptic activity for 10-30 mins, tetanic stimulations (two 100 Hz stimulus trains; 500 ms with 10s intertrain interval) were applied. The peak amplitudes of EPSCs and the slopes between 10-70 % of the peak responses of EPSPs and fEPSPs were measured. Pharmacologically isolated NMDAR-mediated EPSPs were also recorded in some experiments with cells held at -60 mV in the presence of CNQX (10 μM) to block AMPARs and bicuculline to block GABA A R responses. Biochemical experiments-Subcellular fractionation and PSD isolation: Subcellular fractionation of adult male rat (40 to 60 days) forebrains were performed as previously described (18;19) . The approaches used for PSD isolation are described elsewhere (20) (21) (22) . Briefly, the synaptosome fraction was isolated by discontinuous sucrose gradient centrifugation and was solubilized in 0.5% Triton X-100 then centrifuged to obtain the PSD-I pellet. This pellet was re-suspended, solubilized in 0.5% Triton X-100 and centrifuged to obtain the PSD-II pellet. Extracts from individual fractions were finally solubilized in 1% sodium dodecyl sulphate (SDS) and centrifuged at 15,000g for 5min for western blot analysis. Immunoprecipitation and Western blot analysisExperiments were performed as described previously (9;17). In brief, proteins from the P2 (or P1) fraction of adult rat forebrain were dissolved in a lysis buffer containing (mM): Tris-HCl (50, pH 9.0), NaCl (150), 0.5% (v/v) Triton X-100, 1% (w/v) sodium deoxycholate, 0.1% (w/v) SDS, EDTA (2) and sodium orthovanadate (1) . For attached cell homogenates, cells were mechanically dissociated and cell pellets were re-suspended in HNTG buffer (50mM HEPES pH7.5, 150mM NaCl, 1% Triton X-100, 10% glycerol, 1mM ED-TA, 10mM sodium pyrophosphate, 100 mM NaF and 1mM sodium orthovanadate). Solubilized proteins (600-800 μg) were incubated overnight at 4 o C with antibodies, as indicated. The immune complexes were collected with protein Gsepharose beads (Amersham Biosciences) for 2 hs at 4 o C. The blotting analysis was performed by repeated stripping and successive probing with antibodies as indicated. Antibodies used in these experiments include anti-NR1 (Pharmingen), NR2A C-terminal (Upstate), NR2A N-terminal (Santa Cruz), PTPα (17), Src (Oncogene), SrcpTyr416 (Cell Signaling), Src-pTyr527 (Cell Signaling), Chk (Santa Cruz), phosphotyrosine (Upstate), kv3.1b (BD Bioscience) and GluR2/3 (Upstate). Monoclonal ("anti-Csk", mouse, BD Bioscience) and polyclonal (rabbit, Santa Cruz) antibodies against Csk were used to avoid signal overlapping of Csk with IgG heavy chain in Western blotting. To avoid confusion, only the monoclonal Csk antibody raised against the SH2 and SH3 domain of Csk was labeled as "anti-Csk" in this paper. Non-selective mouse or rabbit IgG was utilized for immunoprecipitation as negative control. cDNA transfection-HEK293 or COS7 cells were transfected using the calcium phosphate method (Invitrogen) as per the manufacturer's instruction with expression vectors (pcDNA3 or pRcCMV) containing cDNAs encoding NR1-1a, full length or C-terminal truncated NR2A, v-Src (a gift of Dr. T. Pawson, University of Toronto), Csk (a gift of Dr. K. Harder, Royal Melbourne Hospital), wildtype or mutant neuronal Src (n-Src, Y535F or K303R/Y535F, provided by Dr. S. Hanks, Vanderbilt University), and Src(40-58) (a gift from Dr. M.W. Salter, Hospital For Sick Children, Toronto). To avoid confusion, the n-Src mutants of chicken c-Src used in our experiments are referred to as Y527F and K295R/Y527F. Transfected cells were maintained in DMEM with 10% FBS for 24 hours before lysis. GST pull-down assay-pGEX2th-Csk-ST plasmid was kindly provided by Dr. G. Sun at the University of Rhode Island. Csk S109C mutation was made using QuikChange XL Site-Directed Mutagenesis Kit (Stratagene) as described by the manufacturer. Point mutation was confirmed by DNA sequencing. The GST and GST fusion proteins conjugated with Csk or Csk S109C were produced in E. Coli (BL-21 strain, Invitrogen) with isopropyl-β-D-thiogalactopyranoside (IPTG, 0.1mM) induction. The bead-bound GST fusion proteins or GST alone (15-20 μg) were each incubated with solubilized membrane proteins (600-800 μg) extracted from the adult rat brain tissue or 5 μl 35 S-methionine-labelled NR1 CT peptide and NR2A CT peptide in binding buffer (2% BSA in PBS) overnight at 4 o C. Bound proteins were separated by electrophoresis and detected by Western blotting or autoradiography. 35 S-methioninelabelled NR1 CT peptide and NR2A CT peptide were synthesized in TNT T7 Quick Coupled Transcription/Translation System (Promega) following the protocol recommended by the manufacturer. For dephosphorylation treatment, 5 μl 35 Smethionine-labelled NR2A CT peptide was incubated with 100 units lambda protein phosphatase (λ-PPase, NEB) in the reaction buffer prior to the pull-down assays.
RESULTS
Due to the lack of highly selective inhibitors of Csk kinases we employed a Csk antibody ("anti-Csk"; mouse monoclonal antibody, 2.5 μg/ml, BD Biosciences) that prevents Csk's ability to interact with NR2 subunits (see Fig. 7B ) thereby inhibiting Csk's ability to regulate the phosphorylation of NMDARs by Src. Such an approach is analogous to the use of anti-Src to selectively inhibit Src kinase activity in CA1 neurons (4). Intracellular applications of anti-Csk caused a time-dependent increase in the magnitude of the EPSP slope to 189 ± 11% of that recorded immediately after breakthrough (Fig. 1A,B) . The slope of the CA3-CA1 EPSP largely reflects the underlying AMPAR conductance when extracellular Mg 2+ is present (e.g. 1.3 mM). The enhancement of EPSPs induced by the anti-Csk antibody application subsequently occluded the induction of LTP (Fig. 1B) . Furthermore, the potentiation of EPSPs by anti-Csk was blocked by pre-treating slices with the NMDAR antagonist AP5 (50 μM) or with the Src family kinase inhibitor PP2 (10 μM, 1 h) (Fig. 1A) , indicating that endogenous Csk regulates synaptic plasticity through a Src family kinase and NMDAR dependent mechanism.
We also examined the effects of recombinant Csk supplied through our patch pipette on EPSCs recorded in the whole-cell voltage-clamp configuration. Intracellular applications of Csk had no time-dependent effect on the amplitude of baseline EPSCs (Fig. 1C) , suggesting that endogenous Csk is sufficient to limit Src activity and prevent plasticity of baseline EPSCs. In contrast, recombinant Csk substantially attenuated the induction of LTP. In control recordings lacking Csk, the amplitude of EPSCs were significantly enhanced to 285 ± 32% (mean ± SEM, n=9) after tetanic stimulation (Fig. 1C) . However, application of recombinant Csk (0.1 μg/ml) into neurons through the recording pipettes substantially attenuated LTP of EPSCs (Fig. 1C) . Recordings of fEPSPs performed simultaneously with whole-cell recordings of EPSCs were used to confirm that the magnitude of LTP did not differ in slices from each treatment group (Fig. 1D) .
We next considered if intracellular applications of Csk or its inhibitor (anti-Csk) would alter pharmacologically isolated NMDAR EPSCs. Csk caused no change in the amplitude of these NMDAR-mediated synaptic currents ( Fig. 2A) . In contrast, intracellular applications of anti-Csk caused a substantial and time-dependent increase in the amplitude of these currents that was not mimicked by a non-selective IgG (Fig. 2B ). This anti-Csk induced enhancement was prevented by including the selective Src kinase inhibitory peptide (Src40-58) in the patch pipette together with the antibody (Fig. 2B ). These results imply that endogenous Csk kinases in CA1 neurons constitutively inhibit the Src-dependent potentiation of NMDAR EPSCs. Furthermore, this inhibition is likely complete, as supplementing the neurons with exogenous Csk kinase were without effect on these baseline responses.
To investigate the inhibitory effect of endogenous Csk on excitatory synaptic transmission, we first determined the subcellular distribution of Csk family kinases in the brain. Sequential fractionation of forebrain homogenates was performed from adult rats (40 to 60 days old). The NR1 subunit, PSD-95 (9;18;23) and Src (9;18) were abundant in both the crude synaptosomal membrane (P2) and the synaptosomal membrane (LP1) fractions but little was detected in either the synaptic vesicle-enriched (LP2), the low-speed supernatant (S1, S2) or in the cytosolic (S3) fractions (Fig.  3A) . In contrast, Csk and Chk were found in all the fractions but less Chk was apparent in the P2 and LP1 fractions where a strong NR1 signal was detected (Fig. 3A) . Highly selective antibodies distinguishing between Csk and Chk were employed ( Supplementary Fig. 1 ).
Western blot analysis of the PSD fraction, which is highly enriched with the NR1 subunit and PSD-95, revealed that Src, Csk and to a lesser degree Chk are also present in this fraction (Fig. 3A) . The vesicle-associated membrane protein-2 (VAMP-2) was absent from this PSD fraction. Thus, we hypothesized that Csk family kinases and NMDARs may be closely associated in neurons.
To examine this hypothesis, we performed co-immunoprecipitation experiments using synaptosomal membrane preparations (P2 and LP1 fractions) solubilized under non-denaturing conditions. Both Csk kinases and NMDARs were located in these fractions (Fig. 3A ). An antibody against the NR1 subunit of the NMDAR precipitated neither Kv3.1b (24) (Fig. 3B) . None of these proteins were detected in the immunoprecipitates obtained using a non-selective IgG (Fig. 3B) . Importantly Csk, but not Chk, was found in NR1 immunoprecipitates (Fig. 3C) . Conversely, we also found that antibodies raised against Csk coimmunoprecipitated NMDAR subunits, PTPα and Src but not Kv3.1b nor GluR2/3 (Fig. 3D) .
In addition, NMDAR subunits, including NR1, NR2A and NR2B, were pulled down from the brain using GST-fusion proteins conjugated with Csk (GST-Csk), but not by GST alone (Fig.  3E) . Neither Kv3.1b nor GluR2/3 was pulled down by GST-Csk and much less NMDAR protein was pulled down by Csk containing a defective SH2 domain (serine 109 mutated to a cysteine, (GST-Csk S109C))(26;27) when compared to that using GST-Csk (Fig. 3E) . These data indicate that Csk in the adult brain, but not Chk, complexes with NMDARs via its SH2 domain and forms a signalling complex together with PTPα and Src.
To further test the hypothesis that Csk regulates Src's abilities to control NMDAR activity we turned to CA1 pyramidal neurons acutely isolated from hippocampal slices prepared from young adult rats. Recordings from these neurons are performed within one hour of isolation and are therefore not to be confused with primary cultures of neurons. Concentrations of extracellular agonists and antagonists are tightly controlled using a rapid perfusion system.
Unlike the in situ slice condition, previous studies have shown that isolated CA1 neurons demonstrate enhanced Src kinase activity as NMDA-evoked currents are partially reduced by inhibitors of Src family kinases (4;9). Extracellular application of the Src kinase inhibitor SU6656 (2 μM) inhibited NMDAR currents by about 40% (Fig. 4A,B) . Furthermore, including Csk (0.1 μg/ml) in the patch pipette led to a time-dependent depression of NMDAR currents to about 66% as compared to controls (Fig. 4C,D) . Csk did not alter the reversal potential or the decay time constant of NMDA currents (data not shown). In contrast, applications of boiled Csk had no effect on the amplitude of NMDA currents (Fig. 4D) . We also confirmed the involvement of endogenous Src kinases by pre-treating neurons for 10 mins with either of the Src family kinase inhibitors PP2 (10 μM) or SU6656 (2 μM) prior to breakthrough. Following this blockade of Src kinase Csk failed to inhibit NMDA currents (Fig. 4D) . However, inhibition was spared when neurons were pretreated with the inactive analogue of PP2, PP3 (10 μM) (Fig. 4D) . In order to determine whether Csk was specifically targeting Src as opposed to another Src family kinases such as Fyn, we also included the Src-selective inhibitor peptide Src(40-58) in the patch pipette (3). The inhibition of NMDAR-mediated currents by Csk was also occluded by this inhibitor (Fig. 4D) .
Given our results with isolated CA1 neurons we determined if there was any direct relationship between Csk and the Src-dependent phosphorylation of NR2A subunits expressed in vitro in HEK293 or COS7 cells. When both these proteins were over expressed in these cells, the NR2A subunit co-immunoprecipitated Csk (Fig. 5A) . To examine the effects of increased tyrosine phosphorylation of NR2A on its association with Csk, we co-expressed Csk and NR2A along with v-Src. v-Src lacks the Csk targeting sequence in the Ctail (28) and was detected using an antibody that recognizes the autophosphorylated form of Src (Tyr416) (Fig 5B) . Over-expression of v-Src did not alter the expression of NR2A or Csk but substantially enhanced the tyrosine phosphorylation of NR2A (Fig. 5A,B) . It also increased the amount of Csk that co-precipitated with NR2A (Fig. 5A,B) . The NR2A antibody failed to coprecipitate Csk in the absence of co-expressed NR2A (Fig. 5A ) thus serving as a negative control. The greater the level of v-Src expression, the greater was both the phosphorylation of NR2A subunits and the co-precipitation of Csk ( Fig. 5B  right panel and 5D ). Over expression of the constitutively active form of Src (v-Src) also enhanced co-precipitation of NR2A together with endogenous Csk (Supplementary Fig. 2A ).
To determine if this increase in Csk-NR2A co-precipitation was the result of an enhancement of Src kinase activity or, alternatively, if it was simply due to an increased expression of Src protein, we co-transfected cDNA encoding either constitutively active Src (C-tail Tyr527 mutated to phenylalanine (Y527F)) or inactive Src (lysine 295 in kinase domain was mutated to arginine, in addition to the Tyr527 mutation (Y527F/K295R) (29) . The level of expression of Src was similar in these two groups of cells (Fig.  5C left panel) while the amount of Csk that coprecipitated with the NR2A subunit in cells expressing inactive Src was only 12 ± 3% (n=4) of that in cells expressing active Src (Fig. 5C right  panel and 5E) . Similarly, the co-expression of active Src also significantly enhanced the association of Csk with the NR2B subunit when compared to the co-expression of inactive Src (Supplementary Fig. 2B ). Csk was not precipitated with non-specific IgG from the lysates of cells cotransfected with active Src (Fig. 5C and Supplementary Fig. 2B ). These findings demonstrate that association of Csk with NR2A (and NR2B) is dependent upon Src kinase activity.
Given the potential interactions between Csk and Src-induced phosphorylation of the NR2A subunit we explored the regions of NR2A that might directly interact with Csk. Wild-type or C-tail truncated mutants of NR2A subunits were co-expressed in HEK293 cells together with NR1-1a, active Src (Y527F) and Csk (Fig. 6A) . Csk was co-immunoprecipitated using antibodies directed against the N-terminal of NR2A subunits (Fig. 6B ) or against NR1 subunits (Fig. 6C) . Truncation of NR2A (aa1-837) did not alter the assembly of NMDAR subunits (Fig. 6B,C) . However, it substantially reduced coimmunoprecipitation of Csk ( Fig. 6B-E) , confirming that Csk associates with the NMDAR complex through interactions involving the NR2A subunit C-terminal region.
We further characterized the interaction between Csk and NR2A by performing in vitro GST pull-down assays. Since increased tyrosine phosphorylation of NR2A increased its association with Csk we explored whether the SH2 domain of Csk is specifically responsible for binding to the NR2A subunit. SH2 domains serve as a binding site for phosphotyrosine residues (28;30). The 35 S-labelled peptide corresponding to the C-tail (aa838-1464) of the NR2A subunit was precipitated by GST-Csk but not by GST alone (Fig. 7A) . When the experiment was repeated using GST fusion proteins conjugated with Csk containing a defective SH2 domain(26;31) (GST-Csk S109C), much less NR2A C-tail peptide was pulled-down (Fig. 7A,B) . Furthermore, when the NR2A C-tail peptide was pre-treated with lambda protein phosphatase (λPPase, 100 units, New England Biolabs), which reduced tyrosine phosphorylation of the NR2A C-tail peptide (Fig. 7C) , the amount of NR2A C-tail peptide precipitated with GST-Csk was significantly reduced (Fig. 7A,B) .
Next, we examined the effects of the Csk antibody, anti-Csk (2.5 μg/ml), which was raised using a peptide sequence corresponding to the SH3-SH2 domains of Csk, on these interactions. Anti-Csk dose-dependently reduced the amount of NR2A C-tail peptide pulled down with GST-Csk (Fig. 7A,B) . However, it did not alter the in vitro kinase activity of Csk (data not shown). Applications of non-selective IgG produced no change in the pull-down of the NR2A C-tail peptide (Fig.  7A,B) . Therefore, Csk targets the tyrosine phosphorylated NR2A subunit via its SH2 domain and application of anti-Csk prevents Csk's interactions with the NR2A C-tail. By this means the antibody disrupts Csk's interactions with NMDAR and thereby serves as a functional inhibitor of Csk action on NMDAR activity.
The activity of endogenous Src kinases, as well as the basal level of protein tyrosine phosphorylation of the NR2A subunit, is very low in HEK293 cells (Fig. 7D-G) (32) . Therefore, we examined the potential effect of Csk on tyrosine phosphorylation of the NR2A subunit in this cell line. Increasing Csk expression did not alter the tyrosine phosphorylation of the NR2A subunit (Fig. 7F,G) , demonstrating that Csk does not directly phosphorylate NMDARs. Transfection of wild-type Src into HEK293 cells substantially elevated both Src kinase activity and overall protein tyrosine phosphorylation (Fig. 7D,E) .
Coexpression of Csk in these cells inhibited Src kinase activity (decreased Tyr416 phosphorylation and increased Tyr527 phosphorylation of Src) and reduced overall protein tyrosine phosphorylation (Fig. 7D,E) . Expression of constitutively active Src (Y527F) further augmented Src kinase activity and protein tyrosine phosphorylation, but in this situation Csk did not alter either Src kinase activity or overall tyrosine phosphorylation (Fig.  7D,E) . This result is consistent with a lack of inhibition of constitutively active Src by Csk. Tyrosine phosphorylation of the NR2A subunit was also depressed when Csk was co-transfected in cells expressing wild-type Src but not in cells over-expressing constitutively active Src (Fig.   7F,G ). These results demonstrate that Csk modulates Src-induced NMDAR tyrosine phosphorylation of the NR2A subunit.
DISCUSSION
The importance of Src family kinases in the development of the CNS is well known but their specific role in synaptic transmission in the adult is less well recognized. Disruption of the csk gene in mice (Csk -/-) leads to enhanced Src family kinase activity, resulting in severe defects in neural tube development and early (E9-10) embryonic lethality (27;33) thereby illustrating that Csk is essential for CNS development. In contrast, Chk null mice are viable and demonstrate no histological CNS abnormalities (34) . Nevertheless, a role for Csk in the adult central nervous system had all but been ruled out based on the dramatic downregulation of Csk expression and parallel upregulation of Chk that occurs with CNS maturation (10;11;35-37) . Unexpectedly, our results show that it is Csk that is a critical signalling molecule in controlling excitatory synaptic transmission and plasticity in the hippocampus.
In central neurons, Src increases the open probability of NMDA channels (24) and, in the absence of added extracellular Mg 2+ , enhances NMDAR-mediated currents in cultured hippocampal, slice hippocampal and acutely isolated CA1 neurons (4;9;17). This is likely achieved through phosphorylation of tyrosine residues on NR2A and NR2B subunits (3). For example, Src directly phosphorylates NR2A subunits and Fyn phosphorylates NR2B subunits (3). We have shown that application of recombinant Csk depresses NMDAR responses in acutely isolated CA1 pyramidal neurons taken from young rats. This depression was dependent upon Src family kinase activity as it was entirely occluded by pharmacological blockade using Src family kinase inhibitors (PP2, SU6656). It was also dependent upon the specific activation of Src kinase as it was blocked by the Src-selective inhibitory peptide, Src(40-58) (3). Our results are consistent with Csk inhibiting Src and Fyn regulation of NR2A-and NR2B-containing receptors, respectively. Furthermore, we demonstrated that endogenous Csk depressed NMDAR-mediated EPSCs evoked by stimulation of Schaffer Collaterals.
We also provided evidence that Csk coprecipitates with the NMDAR complex of the adult brain along with Src and PTPα. To elucidate other potential physical associations, we examined the interaction of Csk with NMDAR subunits expressed in non-neuronal cells. We demonstrated co-immunoprecipitation of these proteins following over-expression of Csk and NR2A or NR2B subunits. Furthermore as Src activity was increased and phosphorylation of NR2A and NR2B was enhanced, the association of Csk with the NR2A and NR2B subunits was also augmented. We conclude that the SH2 domain of Csk binds to NR2A and NR2B subunits in a tyrosinephosphorylation-dependent manner. This association likely brings Csk into proximity with Src and Fyn.
Increased Csk activity substantially attenuated NR2A subunit tyrosine phosphorylation in cells co-transfected with Src. In contrast, in cells expressing a mutant Src in which the C-tail tyrosine was mutated to phenylalanine, failed to inhibit NR2A tyrosine phosphorylation. The endogenous level of Src family kinase activity and of basal tyrosine phosphorylation of co-expressed NR2A subunits (32) is very low in HEK293 cells. This allowed us to examine the effect of increasing Csk activity under conditions of very low levels of basal Src activity. Over expression of Csk failed to enhance tyrosine phosphorylation of NR2A subunits under these conditions indicating that Csk does not directly phosphorylate this subunit. Therefore, we conclude that Csk diminishes NMDAR tyrosine phosphorylation via the selective depression of Src kinase activity.
At CA3-CA1 synapses the induction of LTP requires the activation of Src family kinases Src and Fyn. The induction protocol itself activates these kinases, facilitates NMDAR activity and in turn leads to the up-regulation of the synaptic AMPARs responsible for the enhanced EPSPs (38) . However, inhibiting Pyk2, Src or PTPα fails to alter the baseline AMPAR EPSPs recorded in CA1 pyramidal neurons even though they effectively prevent induction of LTP (4;9;17). This implies that Src activity, NMDARs and the subsequent potentiation of EPSP amplitude is either subthreshold or that Src activity is inhibited by endogenous Csk during baseline stimulation. Consistent with the later explanation, intracellular application of Csk did not alter baseline EPSPs in CA1 neurons but substantially reduced the Srcdependent induction of LTP at CA3-CA1 synapses. Basal Csk activity is apparently sufficient to keep Src in check since "anti-Csk" enhanced baseline currents and occluded subsequent induction of LTP. These results are also consistent with previous findings showing that intracellular applications of a Src-activator peptide lead to enhanced NMDAR and AMPAR currents and the occlusion of subsequent LTP (4) while Src inhibitors did not alter the strength of excitatory transmission themselves but did inhibit the induction of LTP (4).
Our results show that the association of Csk with the NMDAR complex is responsible for preventing the Src-dependent up-regulation of NMDARs, which would have occurred during baseline excitatory transmission at CA3-CA1 synapses. Csk also serves as an intrinsic mechanism to provide a "brake" on the induction of LTP by its phosphorylation of Src at its C-tail regulatory site. An additional "brake" to this induction is provided by striatal tyrosine enriched phosphatase (STEP), which in contrast dephosphorylates tyrosine residues required for the activation of Src (39) . On the other hand, protein tyrosine phosphatase α (PTPα) dephosphorylates the regulatory C-tail tyrosine of Src family kinases and directly counteracts the inhibition of Src by Csk (17) . Both Csk and PTPα therefore target phosphorylation of the C-tail tyrosine of Src kinases and provide a counter balancing mechanism for the dynamic regulation of the induction of LTP at CA3-CA1 synapses.
Recent evidence indicates that Src family kinases serve as a convergent point of multiple transmitter pathways that in turn regulate NMDAR function in the hippocampus (3;40-42) . Postsynaptic receptors on CA1 neurons, which are capable of enhancing the activity of Csk, are anticipated to depress NMDAR activity contingent upon their up-regulation by Src family kinases. Csk is itself activated via a PKA-dependent phosphorylation of serine 364 (43;44). In this regard, the catalytic subunit of PKA depresses the upregulation of single NMDA channel activity induced by the Src activator phosphopeptide EPQ(pY)-EEIPIA but fails to alter activity in the absence of this activator when applied to out-side out patches taken from cultured hippocampal neurons (45) .
This PKA-dependent and Srccontingent inhibition of NMDAR currents is mimicked by stimulation of platelet-derived growth factor receptors (45) , indicating a potential physiological mechanism whereby Csk regulates the level of baseline excitatory synaptic transmission in central neurons (42) .
Csk interacts with NMDARs to inhibit their phosphorylation by Src. This Csk interaction is also dependent upon the degree of tyrosine phosphorylation of the NMDARs themselves. The greater the increase in phosphorylation of the receptor by Src, the greater will be the interaction with Csk. Therefore, Csk serves as a "governor" of the Src-dependent positive feedback of NMDARs that occurs during high frequency stimulation. By this means Csk not only regulates baseline CA1 transmission but also serves to limit the enhancement of NMDARs associated with LTP.
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This work was supported by grants from the Canadian Institutes of Health Research to JFM and from the Ontario Heart and Stroke Foundation (NA5448) and NIH (5R01 NS053567-01) to XMY. We thank Dr. M.W. Salter for reading and providing suggestions for this manuscript. We therefore examined the selectivity and cross reactivity of these antibodies initially by using GST-fusion proteins coupled to Csk and Chk. These antibodies demonstrated a high selectivity between Csk and Chk with no cross reactivity ( Supplementary Fig. 2a) . Furthermore, this selectivity was confirmed using cell lysates from the adult brain and the liver. The liver contains no Chk 3 4, 5 and served as a negative control (Supplementary Fig. 2d ). We also examined the ability of anti-Csk to distinguish levels of expression of Csk in additional ways. Firstly, we examined its signal with differing levels of expression of recombinant Csk expressed in fibroblasts grown from Csk-/-transgenic mouse embryos (Supplementary Fig. 2b ). Secondly, we tested the ability of the antibody to detect differential levels of expression Csk in adult brain lysates taken from wildtype and Csk+/-mice which are deficient in Csk ( Supplementary Fig. 2c ). These results validate our subsequent use of these antibodies.
